$Mutation Analysis of TET2 Reveals the Clonal Nature of Refractory Anemia with Ring Sideroblasts$

Mutation Analysis of TET2 Reveals the Clonal Nature of Refractory Anemia with Ring Sideroblasts

Bibliografski detalji
Glavni autori:	Malcovati, L, Brisci, A, Galli, A, Bruno, F, Travaglino, E, Pellagatti, A, Della Porta, MG, Ferrari, M, Boultwood, J, Cremonesi, L, Hellstrom-Lindberg, E, Cazzola, M
Format:	Conference item
Izdano:	2010

Slični predmeti

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
od: Malcovati, L, i dr.
Izdano: (2009)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts
od: Boultwood, J, i dr.
Izdano: (2008)

Differential expression of genes related to JAK-STAT pathway activation or megakaryocyte differentiation/maturation in CD34+cells from patients with refractory anemia with ringed sideroblasts and thrombocytosis (RARS-T)
od: Malcovati, L, i dr.
Izdano: (2007)

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
od: Jacqueline Boultwood, i dr.
Izdano: (2008-04-01)

Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
od: Nikpour, M, i dr.
Izdano: (2010)

NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING
od: Nikpour, M, i dr.
Izdano: (2009)

Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
od: Nikpour, M, i dr.
Izdano: (2009)

YI1 Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
od: Nikpour, M, i dr.
Izdano: (2009)

Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
od: Malcovati, L, i dr.
Izdano: (2011)

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts
od: Nikpour, M, i dr.
Izdano: (2013)

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts.
od: Nikpour, M, i dr.
Izdano: (2013)

Ring sideroblasts and sideroblastic anemias
od: Mario Cazzola, i dr.
Izdano: (2011-06-01)

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
od: Papaemmanuil, E, i dr.
Izdano: (2011)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, i dr.
Izdano: (2009)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
od: Pellagatti, A, i dr.
Izdano: (2009)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
od: Pellagatti, A, i dr.
Izdano: (2011)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, i dr.
Izdano: (2010)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
od: Pellagatti, A, i dr.
Izdano: (2008)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
od: Pellagatti, A, i dr.
Izdano: (2011)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
od: Pellagatti, A, i dr.
Izdano: (2010)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
od: Boultwood, J, i dr.
Izdano: (2007)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
od: Boultwood, J, i dr.
Izdano: (2009)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, i dr.
Izdano: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, i dr.
Izdano: (2010)

Clinical features and course of refractory anemia with ring sideroblasts associated with marked thrombocytosis
od: Julien Broseus, i dr.
Izdano: (2012-07-01)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
od: Pellagatti, A, i dr.
Izdano: (2009)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
od: Pellagatti, A, i dr.
Izdano: (2007)

Mutations of JAK2 and TET2, but not CBL are detectable in a high portion of patients with refractory anemia with ring sideroblasts and thrombocytosis
od: Johanna Flach, i dr.
Izdano: (2010-03-01)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
od: Pellagatti, A, i dr.
Izdano: (2008)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
od: Pellagatti, A, i dr.
Izdano: (2013)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
od: Pellagatti, A, i dr.
Izdano: (2014)

Pyridoxine Refractory Sideroblastic Anemia: Diagnosis and Misdiagnosis
od: Muhammad Matloob Alam, i dr.
Izdano: (2022-10-01)

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression.
od: Jädersten, M, i dr.
Izdano: (2009)

Acquired Sideroblastic Anemia: An exploratory Comparative Statistical Analysis Between Clonal and Non-clonal cases
od: Dina Sameh Soliman, i dr.
Izdano: (2022-08-01)

Del(5q) Myelodysplastic Stem Cells Exhibit Their Clonal Advantage Via Increased Adhesion to the Microenvironment
od: Scharenberg, C, i dr.
Izdano: (2011)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
od: Pellagatti, A, i dr.
Izdano: (2006)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
od: Boultwood, J, i dr.
Izdano: (2010)

Sideroblastic anemia
od: P Bhandari, i dr.
Izdano: (2016-03-01)

Clonal heterogeneity in the 5q- syndrome: p53 expressing progenitors prevail during lenalidomide treatment and expand at disease progression
od: Martin Jädersten, i dr.
Izdano: (2009-12-01)

Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms.
od: Malcovati, L, i dr.
Izdano: (2011)